Subjecting mammary tumor-bearing mice to IGF-1R inhibitor and immune checkpoint blockade was sufficient to mimic the anti-tumor effect of fasting in lung cancer (Ajona et al., 2020). The gene discussed is IGF1R; the disease is breast cancer.